FITC-labeled Drisapersen sodium

• CAT Number: I041411
• Purity: ≥95%

FITC-labeled Drisapersen sodium（Cat No.:I041411）is a modified version of Drisapersen, a drug used to treat Duchenne muscular dystrophy (DMD), with a fluorescent FITC (fluorescein isothiocyanate) label attached. FITC is commonly used in research to visualize and track molecules in biological studies due to its bright fluorescence. Drisapersen, an antisense oligonucleotide, targets and modifies the dystrophin gene to produce a functional form of dystrophin protein, which is crucial for muscle function. The FITC labeling allows for tracking of the drug’s distribution, cellular uptake, and interaction in preclinical studies and research involving gene therapy for DMD.